Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Amy Abalos"'
Autor:
Kalmon D. Post, Michelle Wiltshire-Clement, Amy Abalos, Ellen P. Fischer, Myron Miller, Ernest Benjamin, Thomas J. Iberti, John Oropello, Jacob H. Rand
Publikováno v:
Neurosurgery. 34:389-395
Neurosurgical patients are at high risk for the development of thrombosis and thromboembolism. We compared the perioperative clotting factor and coagulation parameters of 20 patients undergoing elective craniotomy for brain tumors to those of 20 pati
Publikováno v:
American Journal of Critical Care. 1:32-36
OBJECTIVES: To estimate the incidence of silent myocardial ischemia, its pattern over time and its relationship to the time and mode of weaning high-risk cardiac patients after noncardiac surgery. DESIGN: Prospective study with random assignment to o
Autor:
Matthew R. Belmont, Michiko Okamoto, John J. Savarese, Cynthia A. Lien, Amy Abalos, Doreen L. Wray Roth
Publikováno v:
Anesthesiology. 91(1)
Background The authors examined the plasma concentrations of the isomers of mivacurium and its pharmacodynamics during spontaeous and neostigmine-facilitated recovery after a mivacurium infusion. Methods Sixteen patients receiving nitrous oxide-opioi
Autor:
Cynthia A. Lien, Charleen Hollmann, Amy Abalos, Robert E. Kelly, Matthew R. Belmont, Hugh C. Hemmings
Publikováno v:
Journal of clinical anesthesia. 8(8)
Study Objective: To compare sevoflurane-nitrous oxide with propofol-nitrous oxide for the induction and maintenance of anesthesia, and to determine the rates of recovery following each anesthetic. Design: Randomized, controlled study. Setting: Teachi
Autor:
Matthew R. Belmont, John J. Savarese, Cynthia A. Lien, Virginia D. Schmith, Amy Abalos, David F. Kisor
Publikováno v:
Anesthesiology. 84(2)
Background Cisatracurium, one of the ten isomers in atracurium, is a nondepolarizing muscle relaxant with an intermediate duration of action. It is more potent and less likely to release histamine than atracurium. As one of the isomers composing atra
Autor:
John J. Savarese, Matthew R. Belmont, Martha M. Abou-Donia, Larissa Eppich, Steve Quessy, Cynthia A. Lien, Amy Abalos
Publikováno v:
Anesthesiology. 82(5)
Background Atracurium consists of a mixture of ten stereoisomers. One of these isomers, 51W89, is a potent intermediate-acting nondepolarizing neuromuscular blocking agent. Its ED95 is 0.05 mg.kg-1 in patients receiving nitrous oxide/opioid anesthesi
Autor:
John J. Savarese, Matthew R. Belmont, Amy Abalos, Larissa Eppich, Martha M. Abou-Donia, Steve Quessy, Cynthia A. Lien
Publikováno v:
Anesthesiology. 82(5)
Background Atracurium is a mixture of ten stereoisomers. 51W89, one of these isomers, is a potent nondepolarizing intermediate-duration neuromuscular blocking agent. Preclinical studies have shown 51W89 to be significantly more potent than atracurium
Publikováno v:
Survey of Anesthesiology. 44:162
The hypothesis of this study was that, in a given patient, recovery from a tracheal intubating dose of mivacurium would indicate the time course of spontaneous recovery after discontinuation of an infusion of mivacurium. Thirty-eight male patients co
Publikováno v:
Anesthesiology. 89:983A
Autor:
Larissa Eppich, Cynthia A. Lien, Steve Quessy, John J. Savarese, Matthew R. Belmont, Martha M. Abou-Donia, Amy Abalos
Publikováno v:
Survey of Anesthesiology. 40:237
Background Atracurium consists of a mixture of ten stereoisomers. One of these isomers, 51W89, is a potent intermediate-acting nondepolarizing neuromuscular blocking agent. Its ED95 is 0.05 mg.kg-1 in patients receiving nitrous oxide/opioid anesthesi